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Abstract
The specific transcytosis of polypeptides, demonstrated in the nasal respiratory mucosa of the rabbit, seems to be involved
in antigen sampling at the airway entry, since absorption has been shown only to occur if lymphoid aggregates are present
beneath the epithelium and to be proportional to aggregate volume. Nanoparticles and many polypeptides besides the two
previously tested (i.e. carbocalcitonin (CCT) and adrenocorticotropic hormone) should be transportable, in agreement with
the vesicular transcytosis and antigen sampling hypothesis. Thus unidirectional mucosa-submucosa and opposite fluxes (Jms,
Jsm) and the corresponding net fluxes (Jnet) of uncoated or polypeptide-coated polystyrene nanospheres (diameter : about
0.5 Wm) have been measured with the aid of spectrophotometry and quantitative dark-field microscopy. No net transport has
been observed for uncoated beads, whereas it has always been shown for polypeptide-coated beads, although to different
extents. The selectivity sequence for the polypeptides tested is as follows: BSAwenkephalinIanti-BSA IgGwIgAwCCT
winsulin9 anti-insulin IgG. With the exception of BSA and enkephalin-coated beads, whose Jnet is very small, in all the
other cases the apparent affinities for receptors seem to be equal or similar; just over 6% polypeptide coating on the
nanosphere is sufficient to elicit maximal transport; finally, transport seems to require many cooperating binding sites
between the single nanosphere and receptors or one or many non-cooperating binding sites, but with a threshold number of
polypeptide molecules adsorbed on the nanosphere to reach a minimal binding probability. ß 1999 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Transepithelial active absorption of carbocalcito-
nin (CCT) and adrenocorticotropic hormone
(ACTH) has been shown to be present across the
respiratory mucosa covering the upper nasal concha
of the rabbit [1]. The transport has been demon-
strated to be supported by receptor-mediated endo-
cytosis and transcytosis across the epithelium [2^4]
and to be preclusively correlated and proportional
to the total volume of lymphoid cell aggregates in
the mucosa [5]. On this basis it has been concluded
that the function of this transcytosis of polypeptides
may be antigen sampling from the nasal lumen at the
airway entry [5].
This paper and the following one examine the anti-
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gen sampling hypothesis further. In line with it we
show in this paper that many di¡erent polypeptides
besides CCT and ACTH can be selectively recog-
nized by receptors and transcytosed; they have
been presented adsorbed on nanoparticles, as the
CCT, adsorbed on nanoparticles, has been previously
observed to be equally transported in agreement with
vesicular transcytosis [3]. In the following paper, us-
ing polypeptide-covered £uorescent nanoparticles, we
also report that the transcytosis is localized in limited
regions of the epithelium, lying on lymphoid aggre-
gates, and that the epithelial cells involved are non-
ciliated microvillar cells.
2. Materials and methods
Male New Zealand rabbits, weighing approx. 3 kg,
were killed by cervical dislocation and the nasal mu-
cosae from the roof of both nostrils were mechani-
cally excised very carefully, washed with Krebs-Hen-
seleit saline at room temperature and mounted on
frames between two Te£on chambers. The exposed
part of the mucosa (area: 0.3 cm2) corresponded to
that covering the upper concha. The two chambers
were ¢lled with 1 ml Krebs-Henseleit saline, bubbled
with pre-humidi¢ed 95% O2+5% CO2 to oxygenate
the tissue, maintain the pH at 7.4 and stir the solu-
tion. The experiments were carried out at a moni-
tored temperature of 27 þ 1‡C unless otherwise indi-
cated; at this temperature the short-circuit current,
index of ion transports, was half that measured at
37‡C, but the isolated mucosa was stable and viable
for hours [6]. The viability of the epithelium was
checked at the beginning, during and at the end of
each experiment by measuring the transepithelial
electrical potential di¡erence, as previously reported
[1,6].
2.1. Flux measurements
The unidirectional mucosa-submucosa and oppo-
site transports of native or polypeptide-covered latex
nanospheres were determined for 2 h, one on the
right and the other on the left mucosa from the
same animal (with random combinations), with the
protocol previously described [3]. Transports were
expressed as £uxes (nanospheres transported cm32
h31 : nan cm32 h31). Both £uxes were considered
unidirectional since the maximal concentration of
nanospheres reached in the £ux chamber was 1034^
1035 compared to that applied in the opposite donor
chamber. The bead concentration in the donor cham-
ber, measured on 10 Wl samples taken at the begin-
ning (1 min after contact with the tissue) and at the
end of the 2 h experiment, proved not to be signi¢-
cantly di¡erent in any case (initial concentration:
(3.30 þ 0.03)U1011 nanospheres/ml, n = 172; ¢nal
concentration: (3.25 þ 0.03)U1011 nanospheres/ml,
n = 172).
The latex nanoparticles were ‘polybead polystyrene
microspheres’ (nominal diameter: 0.5 Wm; actual di-
ameter of the lots used: 0.480^0.499 Wm) produced
by Polysciences (Warrington, PA, USA). For the
concentration measurements a Lambda 5 spectro-
photometer (Perkin Elmer, Norwalk, CT, USA)
was used (wavelength = 600 nm). To prepare the cal-
ibration straight line the reference bead concentra-
tions were predetermined by a Burker’s chamber
after adequate dilution. The nanospheres transported
in the 2 h experiment were measured exclusively by
Burker’s chamber due to their very low concentra-
tion. All determinations in Burker’s chamber were
carried out under observation with an Eclipse E600
dark-¢eld microscope (Nikon Europe, Badhoeve-
dorp, The Netherlands) at a 400U magni¢cation,
taking advantage of Tyndall’s e¡ect. With a Burker’s
chamber obtained in a 1.5 mm thick glass slide, the
ratio between the measured and calculated value of
the nanospheres was 1.
The polypeptides were adsorbed on nanoparticles
by a method previously set up [3,7]. Polypeptide con-
centration in the medium used for the adsorption
process was 6.5U1036 M (unless otherwise speci¢ed).
Still unbound surface sites were completely blocked
with bovine serum albumin (BSA) [3,7].
In one set of experiments the beads used were not
covered with polypeptide. Under these conditions,
when placed in the Krebs-Henseleit saline, they
tend to adsorb and aggregate, so the donor saline
and saline with transported beads were sonicated at
the beginning and end of the experiment, just before
carrying out the determinations. Moreover, the do-
nor saline was completely withdrawn and renewed
every 30 min, as this operation proved su⁄cient to
maintain a constant free bead concentration.
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2.2. Protein determination, materials and bathing
salines
The protein covering of the nanospheres was only
evaluated for insulin by measuring the protein in the
covering incubation medium before and after incu-
bation with nanospheres. The Bradford method (mi-
croassay; measurement range: 1^25 Wg/ml protein)
was used to determine the proteins [8].
BSA, puri¢ed human colostral immunoglobulin A
(IgA), murine monoclonal anti-human insulin immu-
noglobulin G1 and anti-BSA immunoglobulin G2
(anti-ins. IgG and anti-BSA IgG) were supplied by
Sigma (St. Louis, MO, USA) and bovine Na-insulin
and enkephalin ([Leu 5]enkephalin) by Calbiochem
(AG Luzern, Switzerland). Carbocalcitonin ([1,7
Asu]eel calcitonin or elcatonin, CCT) was donated
by ISF-Biomedical Research Laboratories (Trezzano,
Milan, Italy).
The Krebs-Henseleit solution had the following
composition (mM): 142.9 Na, 5.9 K, 2.5 Ca2,
1.2 Mg2, 127.7 Cl3, 24.9 HCO33 , 1.2 SO
23
4 , 1.2
H2PO34 , 5.5 glucose; pH 7.4. The concentration of
the polypeptides added to the Krebs-Henseleit saline
was always molal, unless otherwise speci¢ed.
2.3. Statistics
The results are expressed as means þ standard er-
rors (S.E.). Student’s t-test for unpaired or, when
possible, for paired data was used for statistical anal-
ysis. Interpolating sigmoidal or hyperbolic curves
were calculated by non-linear regressions.
3. Results
3.1. Transepithelial £uxes of native or polypeptide-
coated nanospheres
Table 1 shows that uncoated nanospheres do
not display any signi¢cant net £ux across the respi-
ratory mucosa of the upper concha, in agreement
with a previous observation [3]. Conversely, BSA-
coated nanospheres (BSA-cn, BSA MW = 66 000)
display a relatively very small but highly signi¢cant
net absorption of about 2U106 nan cm32 h31: The
BSA coating was apparently partial as it occurred
in the presence of only 6.5U1036 M BSA (0.043
g%, w/v); however, the subsequent washings with
5% BSA (w/v), to block all still unbound surface
sites, completely covered the nanospheres with
BSA. The a⁄nity of receptors to BSA should there-
fore be very slight. The equally small and signi¢cant
net £ux of enkephalin-coated nanospheres (enk-cn),
which does not appear signi¢cantly di¡erent from
that of BSA-cn, can be originated either by the en-
kephalin adsorbed (in the presence of 6.5U1036 M
Table 1
Transepithelial £uxes of native or polypeptide-covered nanospheres
Covering n Jms Jsm Jnet
Uncovered 5 3.94 þ 0.48 3.37 þ 0.44 0.50 þ 0.38
Covered with
1. BSA 11 6.02 þ 0.60cc 4.15 þ 0.30 1.87 þ 0.38**
2. enkephalin 6 7.26 þ 0.53cc 4.66 þ 0.09 2.60 þ 0.53**
3. carbocalcitonin 6 12.10 þ 1.40cc 5.80 þ 0.80 6.30 þ 1.20**
4. insulin 30 10.56 þ 0.70cc 3.45 þ 0.29 7.10 þ 0.57**
5. IgA 9 9.92 þ 0.97cc 3.83 þ 0.11 6.10 þ 0.91**
6. anti-BSA IgG 6 10.15 þ 1.24cc 4.08 þ 0.34 6.06 þ 0.94**
7. anti-insulin IgG 13 12.69 þ 1.06cc 3.86 þ 0.26 8.83 þ 0.88**
After 30 min preincubation, 3.3U1011/ml native or polypeptide-covered nanospheres (polystyrene, 0.5 Wm diameter) were added to the
mucosal or submucosal compartment, and the overall corresponding unidirectional transports during a 2 h period were determined by
a Burker chamber and expressed as equivalent £uxes (Jms, Jsm ; 106 nan cm32 h31) ; the net £ux (Jnet) was calculated from their di¡er-
ence. Bead covering was carried out by incubating the nanospheres with the 6.5U1036 M polypeptide at 37‡C for 90 min. The results
are presented as means þ S.E.; n, number of experiments.
ccP6 0.01 compared with the corresponding Jsm.
**P6 0.01 compared with zero.
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enkephalin) or by the BSA equally adsorbed (during
washings).
Coating with polypeptides with a higher relative
molecular weight than enkephalin (MW = 555.6),
such as carbocalcitonin (MW = 3362), insulin
(MW = 6000), monomeric anti-BSA or anti-insulin
IgG (MW = 146 000) or dimeric secretory IgA
(MW = 385 000), signi¢cantly increases the net £ux
to 6^9U106 nan cm32 h31 (P6 0.01 compared both
with uncoated and BSA-coated nanospheres). Thus
these polypeptides should be recognized by receptors
much more than BSA, all the more so because they
are present with fewer molecules adsorbed than BSA
(in fact at the concentration used in the covering
medium, i.e. 6.5U1036 M, these polypeptides should
block only a small number of adsorption sites: see
further insulin adsorption as a function of its con-
centration). Finally it should be emphasized that
anti-insulin IgG-cn exhibit a net £ux signi¢cantly
greater than that of anti-BSA IgG-cn or IgA-cn
(P90.05).
Unlike the mucosa-submucosa unidirectional
£uxes (Jms), whose values largely depend on the coat-
ing kind, the opposite unidirectional £uxes (Jsm) dis-
play values generally independent of the coating, as
they are not signi¢cantly di¡erent from one another
and £uctuate in the narrow range of 3^4U106 nan
cm32 h31 (uncovered beads or beads covered with
BSA, insulin, IgA, anti-BSA IgG, anti-insulin IgG).
Only in the case of enkephalin and carbocalcitonin
do Jsm values £uctuate in the small (but signi¢cant)
higher range of 4^6U106 nan cm32 h31.
3.2. Net absorption of carbocalcitonin-coated
nanospheres
In the case of CCT-cn, £uxes of beads coated at
di¡erent concentrations of the polypeptide in the
covering medium were also measured (Table 2); the
nanosphere concentration was that usually ¢xed
(3.3U106 nan/ml). As a consequence of this proce-
dure, di¡erent CCT amounts should be adsorbed
per nanosphere. Under these conditions the sub-
mucosa-mucosa unidirectional £ux (Jsm) was unaf-
fected: Jsm was not signi¢cantly di¡erent at the dif-
ferent coating concentrations, in line with the
observation that Jsm does not depend on or is only
slightly a¡ected by coating (Section 3.1). Conversely,
the mucosa-submucosa unidirectional £ux (Jms) and
the net £ux (Jnet) increased with coating CCT con-
Table 2
Transepithelial £uxes of nanospheres covered with CCT at di¡erent concentrations
CCT concentration (M) n Jms Jsm Jnet
a. 3.2U1036 6 6.5 þ 0.6c 4.7 þ 0.6 1.8 þ 0.4**
b. 6.5U1036 6 12.1 þ 1.4cc 5.8 þ 0.8 6.3 þ 1.2**
c. 9.7U1036 6 13.6 þ 1.3cc 4.7 þ 0.4 8.9 þ 1.3**
d. 19.5U1036 6 15.2 þ 1.2cc 6.0 þ 0.5 9.2 þ 1.0**
Native nanospheres (3.3U1011 nan/ml) were exposed to CCT at di¡erent concentrations, at 37‡C for 90 min. Then the mucosa-submu-
cosa and opposite transepithelial £uxes (Jms, Jsm) and their di¡erence (Jnet) were measured by the usual procedures at 27‡C. Fluxes
are expressed as 106 nan cm32 h31. Results are reported as means þ S.E.; n, number of experiments.
c, ccP6 0.05 or 0.01 compared with the corresponding Jsm.
**P6 0.01 compared with zero.
Fig. 1. Net £uxes of CCT-coated nanospheres as a function of
CCT concentration in the covering medium and, as a conse-
quence, of CCT adsorbed on nanospheres. Data points, pre-
sented as means þ S.E. (n = 6 for each data point), correspond
to the Jnet values reported in Table 2. The interpolating sigmoi-
dal curve (dashed line) has been calculated on the basis of these
data.
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centrations to reach a maximum at about 10 WM
(Table 2).
By plotting net £uxes versus coating CCT concen-
trations (Fig. 1), the best ¢t for data points is ob-
tained with a sigmoidal curve whose S0:5 is 5.1 þ
1.1 WM, Jmax (9.3 þ 0.7)U106 nan cm32 h31, reached
at about 10^15 WM CCT; the Hill number is 3.3;
r2 = 0.986 (P6 0.01). At the reference concentration
of 6.5 WM CCT, Jnet is about 68% Jmax. Alterna-
tively, data points can be interpolated by a hyperbola
(r2 = 0.961; P6 0.01), with Km = 4.6 þ 09 WM and
Jmax = (10.2 þ 1.2)U106 nan cm32 h31 ; however, to
have an r2 comparable with that obtained with the
sigmoid, the hyperbola calculated intercepts the x-
axis at a threshold concentration (approx. 3 WM)
below which transport is not activated.
3.3. Net absorption of insulin-coated nanospheres
Nanosphere coating with insulin and £uxes of in-
sulin-cn have been examined in much more detail.
First, the net £ux observed with nanospheres cov-
ered at the reference concentration of 6.5U1036 M
insulin was studied in relation to its metabolic de-
pendence. Table 3 demonstrates that Jms is about
twice as large at 37‡C as at 27‡C (P6 0.05); Jsm is
not signi¢cantly a¡ected, in agreement with a passive
nature; Jnet displays a thermic coe⁄cient Q10 equal
to 2.2, in agreement with metabolic dependence.
Table 3 also reports that, by treating the tissue
with metabolic inhibitors (3U1033 M mono-
iodoacetate+1034 M dinitrophenol), net £ux is re-
duced to a level not signi¢cantly di¡erent from zero.
Second, insulin adsorbed on nanospheres as a
function of insulin concentration in the covering me-
dium has been measured. Fig. 2 shows the results:
the insulin adsorbed increases with hyperbolic ki-
netics. The kinetics analysis shows that the maximal
amount of insulin adsorbed per nanosphere is equal
Fig. 2. Insulin adsorbed on nanospheres as a function of insulin
concentration in the covering medium. The covering medium
(Krebs-Henseleit saline) contained insulin at di¡erent concentra-
tions; the nanosphere concentration was 3.3U1011 nan/ml; in-
cubation was performed for 90 min at 37‡C as usual. The insu-
lin in the medium was measured before and after the covering
incubation; the insulin remaining adsorbed on the beads was
calculated from the di¡erence of these two determinations. The
ordinate on the left indicates the Wmoles of insulin adsorbed
per nanosphere as a function of the WM insulin concentration
in the medium (lower abscissa); the ordinate on the right indi-
cates the total Wg of insulin adsorbed on all the nanospheres
present in the medium as a function of Wg/ml insulin in the me-
dium (upper abscissa). The data points are the means þ S.E. of
the results of four separate covering experiments. The dashed
line represents the interpolating hyperbola.
Table 3
E¡ect of temperature, metabolic inhibitors and insulin concentration on transepithelial £uxes of insulin-covered nanospheres
Experiment conditions n Jms Jsm Jnet
a. 27‡C 13 11.06 þ 1.47cc 3.96 þ 0.57 7.10 þ 1.15**
b. 37‡C 4 20.90 þ 3.60cc 4.20 þ 0.60 16.70 þ 3.10**
c. MIA+DNP 8 8.69 þ 2.16cc 7.12 þ 2.04 1.57 þ 2.07
d. Covering with 4.7U1034 M insulin 6 13.80 þ 2.31cc 4.01 þ 0.22 9.80 þ 2.12**;ns
Under experiment conditions a, b and c bead covering was carried out with 6.5U1036 M insulin at 37‡C for 90 min; under condition
d, the insulin concentration during covering was increased to 4.7U1034 M; under all conditions, the bead concentration was
3.3U1011 nan/ml. The transepithelial £uxes (Jms, mucosa-submucosa; Jsm, submucosa-mucosa; Jnet, Jms3Jsm) were measured by the
usual procedures, at 27‡C, with the exception of condition b (37‡C). The £uxes are expressed as 106 nan cm32 h31. Monoiodoacetate
(MIA) = 3U1033 M; dinitrophenol (DNP) = 1034 M. The results are presented as means þ S.E.; n, number of experiments.
ccP6 0.01 compared with the corresponding Jsm.
**P6 0.01 compared with zero.
nsNot signi¢cantly di¡erent compared with condition a.
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to (25.5 þ 2.0)U10314 Wmol/nan; S0:5 ( = Km) is 94.8
þ 15.3 WM. Thus at the reference coating concentra-
tion of 6.5 WM, that we used for all polypeptides
examined, the insulin adsorbed is only about 6% of
the maximum adsorbable per nanosphere. Fig. 2 also
shows the total insulin bound to all the nanospheres
present (in Wg) as a function of the insulin concen-
tration in Wg/ml; 2800 Wg/ml is the maximal concen-
tration of soluble bovine insulin which can be
reached. At this concentration 420 Wg insulin is ad-
sorbed on all the nanospheres present, i.e. about 83%
of the calculated maximal amount of adsorbable in-
sulin (505 Wg).
Third, in spite of the fact that at the reference
coating concentration of 6.5 WM the adsorbed insulin
is only 6% of the maximum adsorbable, if £uxes of
nanospheres coated at the maximal reachable con-
centration of soluble insulin (4.7U1034 M, i.e. 2800
Wg/ml) are measured, a small, not signi¢cant increase
of Jms and Jnet is obtained (Table 3d); Jsm does not
change at all, as predicted. Thus net absorption is
already maximal or almost maximal (70% of the
maximum) at a coating concentration of 6.5U1036
M, i.e. at a concentration much lower than that able
to cover the nanosphere completely with insulin. It is
noteworthy that CCT-cn also display about 70% of
maximal transport, when coating occurs with
6.5U1036 M carbocalcitonin. Thus it seems that
the apparent a⁄nity of receptors for insulin and
CCT is very similar and a few molecules of these
polypeptides adsorbed on the nanosphere are su⁄-
cient to o¡er the maximal binding and transport
probability.
4. Discussion
Four main conclusions can be drawn from the
results reported.
First, in agreement with and in further support of
the hypothesis of antigen sampling [1,4,5], the trans-
port system seems to accept many di¡erent polypep-
tides with very di¡erent molecular weights, besides
CCT and ACTH; moreover, it also accepts them
on nanoparticles, in agreement with vesicular trans-
cytosis. The net absorption of coated nanoparticles is
related to active transport as it is strongly a¡ected by
temperature variations (Q10 = 2.2) and completely
abolished by metabolic inhibitors; this has also
been observed for the net transport of free CCT
not adsorbed on nanospheres [1].
Second, uncoated beads are not transported and
transport selectivity is shown for the di¡erent poly-
peptides carried by nanospheres, in agreement with
the previous conclusion that active transport should
be supported by receptor-mediated endocytosis
(RME) [2^4]. On the basis of the results reported
in Table 1, Fig. 3 summarizes transport selectivity,
reporting the net transports of the uncovered or pol-
ypeptide-covered nanospheres as histograms ordered
according to their increasing values; the transport
ratios, taking BSA-cn as a reference, are calculated
and reported, as well as the statistical probability for
the di¡erences between transports. Besides the fact
that uncovered beads do not exhibit any signi¢cant
net £ux, the ¢gure shows that nanospheres com-
pletely covered with BSA display a signi¢cant but
very small net £ux. No increase in transport, com-
pared with that of BSA-cn, is obtained with nano-
spheres coated with enkephalin+BSA, so it is doubt-
ful that enkephalin can be recognized by receptors, at
least better than BSA: either the sequence of enke-
phalin amino acids (Tyr-Gly-Gly-Phe-Leu) is not rec-
ognized by receptors, or it is recognized with the
same a⁄nity of sequences present in BSA, or the
small enkephalin molecules are too deeply buried
Fig. 3. Net £uxes of native or polypeptide-covered nanospheres
(histograms) with the calculated relative values, the net £ux of
BSA-coated nanospheres being taken as reference. The histo-
grams represent the mean þ S.E. (number of experiments in pa-
rentheses). **P6 0.01 compared with zero; W, 9, 6 , 6 , not
signi¢cantly di¡erent, marginally signi¢cant, P6 0.05, P6 0.01
compared with the preceding histogram.
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among the larger BSA molecules, all adsorbed on the
bead surface, so that much greater enkephalin con-
centrations in the covering medium would be needed
to produce an e¡ect of any extent. By contrast, net
transport signi¢cantly increases by 3^4 times that of
BSA-cn when the nanospheres are coated with anti-
BSA IgG, IgA, CCT and insulin, and further in-
creases to almost 5 times with anti-insulin IgG. In
all these cases BSA was also adsorbed to block the
uncovered surface sites. Considering that the analysis
performed in the insulin case shows that only about
6% of the single nanosphere surface is covered by the
tested polypeptide at the reference covering concen-
tration of 6.5U1036 M, it is clear that the majority
of the bead surface is occupied by BSA and the
whole increase in transport is related to a few mole-
cules of the polypeptide tested. Even if the adsorbed
molecules of the polypeptide are considerably in-
creased (see the CCT case), even so as to cover the
nanosphere completely (see insulin), nanosphere net
transport displays only a modest increase. The con-
clusion is that, at the reference covering concentra-
tion, although the adsorbed molecules only cover a
minimal area of the bead surface, the binding and
transport probability are almost maximal. As for the
tested antibodies, the coating and transport kinetics
were not determined. However, at the reference cov-
ering concentration of 6.5U1036 M, anti-BSA IgG-
cn and IgA-cn exhibit net transports not signi¢cantly
di¡erent from those of CCT-cn and insulin-cn, and
anti-insulin IgG-cn only marginally larger. Thus the
a⁄nity of these antibodies for receptors should be
equal to or smaller than but certainly not greater
than that displayed by CCT or insulin. It is to em-
phasize that adsorption of the polypeptide on the
nanoparticle forces the molecule into positions that
do not necessarily represent the best orientation for
easy binding to receptors. Hence the determined af-
¢nities for receptors (CCT, insulin) or those reason-
ably presumable (IgA, anti-BSA IgG, anti-insulin
IgG) can only be the apparent a⁄nities of the poly-
peptide adsorbed on the bead: these apparent a⁄n-
ities do not necessarily correspond to the actual af-
¢nities of the free polypeptides. That being said, it is
worth noting that in rat intestinal mucosa, covering
follicles of Peyer patches, nanoparticles of the same
material and size, coated with the same human co-
lostral IgA, are transepithelially transported with a
ratio of 3.7 þ 1.3 (n = 7) compared with nanoparticles
coated with BSA only [9], in accordance with the
present ¢ndings for nasal mucosa (ratio: 3.3).
Third, the kinetics of net CCT transport as a func-
tion of CCT concentration in the coating medium,
and thus as a function of CCT molecules adsorbed
per nanosphere, is sigmoidal, with a Hill number of
3.3. The probability that nanospheres are trans-
ported should be related to the probability that bind-
ing points are formed between nanospheres and re-
ceptors; the latter probability is proportional to the
number of polypeptide molecules adsorbed on the
nanosphere. Thus the kinetics should be hyperbolic.
However, if the single nanosphere preferentially re-
quires more than one binding point, to be forced and
more ¢rmly entrapped in the forming vesicle, and the
settlement of one of them facilitates the further set-
tlement of the other binding points, the kinetics
should become sigmoidal. The Hill number obtained
suggests that there are three cooperating binding
sites per nanosphere. Alternatively, the data points
in Fig. 1 can be interpolated by a hyperbola, how-
ever, intercepting the x-axis at a threshold concen-
tration. In this case nanospheres would be trans-
ported in relation with the formation of only one
or many, non-cooperating binding sites, but a thresh-
old number of polypeptide molecules adsorbed on
the nanosphere would be requested to reach a mini-
mal binding probability.
Fourth, Jsm is independent of temperature and
coating, or minimally dependent on coating. Thus
Jsm seems to depend on a passive non-speci¢c per-
meation. Considering bead dimension, it is unlikely
that the nanosphere passive £ux crosses intercellular
junctions, especially so because it is not a¡ected by
regulation of actin cytoskeleton, which controls in-
tercellular junctions [3]. Jsm should cross the epithe-
lium through a few very large paracellular pores,
much more similar to nanolesions of a negligible
total area, so as not to short circuit the transepithe-
lial electric potential di¡erence.
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